385 related articles for article (PubMed ID: 17947464)
21. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
[TBL] [Abstract][Full Text] [Related]
22. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.
Lloveras E; Solé F; Florensa L; Besses C; Espinet B; Gil M; Pérez-Vila ME; Pedro C; Abella E; Sans-Sabrafen J; Woessner S
Cancer Genet Cytogenet; 2002 Jan; 132(1):25-9. PubMed ID: 11801304
[TBL] [Abstract][Full Text] [Related]
23. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
[TBL] [Abstract][Full Text] [Related]
24. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Fonseca R; Debes-Marun CS; Picken EB; Dewald GW; Bryant SC; Winkler JM; Blood E; Oken MM; Santana-Dávila R; González-Paz N; Kyle RA; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR
Blood; 2003 Oct; 102(7):2562-7. PubMed ID: 12805059
[TBL] [Abstract][Full Text] [Related]
25. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
[TBL] [Abstract][Full Text] [Related]
26. [Chromosome 13q deletion detected by interphase FISH in multiple myeloma: a study of 100 cases in China].
Li Q; Lu Y; Wang YF; Liu XP; Qi JY; Zou DH; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1979-82. PubMed ID: 19950573
[TBL] [Abstract][Full Text] [Related]
27. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
28. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma.
Chiecchio L; Protheroe RK; Ibrahim AH; Cheung KL; Rudduck C; Dagrada GP; Cabanas ED; Parker T; Nightingale M; Wechalekar A; Orchard KH; Harrison CJ; Cross NC; Morgan GJ; Ross FM
Leukemia; 2006 Sep; 20(9):1610-7. PubMed ID: 16826223
[TBL] [Abstract][Full Text] [Related]
29. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
[TBL] [Abstract][Full Text] [Related]
30. 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Chang H; Qi X; Jiang A; Xu W; Young T; Reece D
Bone Marrow Transplant; 2010 Jan; 45(1):117-21. PubMed ID: 19448682
[TBL] [Abstract][Full Text] [Related]
31. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance.
Drach J; Angerler J; Schuster J; Rothermundt C; Thalhammer R; Haas OA; Jäger U; Fiegl M; Geissler K; Ludwig H; Huber H
Blood; 1995 Nov; 86(10):3915-21. PubMed ID: 7579361
[TBL] [Abstract][Full Text] [Related]
32. Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia.
Moorman AV; Clark R; Farrell DM; Hawkins JM; Martineau M; Secker-Walker LM
Genes Chromosomes Cancer; 1996 May; 16(1):40-5. PubMed ID: 9162196
[TBL] [Abstract][Full Text] [Related]
33. Random aneuploidy in neoplastic and pre-neoplastic diseases, multiple myeloma, and monoclonal gammopathy.
Amiel A; Gronich N; Yukla M; Suliman S; Josef G; Gaber E; Drori G; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2005 Oct; 162(1):78-81. PubMed ID: 16157205
[TBL] [Abstract][Full Text] [Related]
34. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.
Avet-Loiseau H; Li JY; Morineau N; Facon T; Brigaudeau C; Harousseau JL; Grosbois B; Bataille R
Blood; 1999 Oct; 94(8):2583-9. PubMed ID: 10515861
[TBL] [Abstract][Full Text] [Related]
35. Genomic abnormalities in monoclonal gammopathy of undetermined significance.
Fonseca R; Bailey RJ; Ahmann GJ; Rajkumar SV; Hoyer JD; Lust JA; Kyle RA; Gertz MA; Greipp PR; Dewald GW
Blood; 2002 Aug; 100(4):1417-24. PubMed ID: 12149226
[TBL] [Abstract][Full Text] [Related]
36. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
Oh S; Koo DH; Kwon MJ; Kim K; Suh C; Min CK; Yoon SS; Shin HJ; Jo DY; Kwak JY; Kim JS; Sohn SK; Joo YD; Eom HS; Kim SH; Kim YS; Kim C; Mun YC; Kim H; Lee DS; Lee JH;
Ann Hematol; 2014 Aug; 93(8):1353-61. PubMed ID: 24671365
[TBL] [Abstract][Full Text] [Related]
37. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal gammopathy of undetermined significance].
Chaïbi P; Merlin L; Thomas C; Piette F
Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
[TBL] [Abstract][Full Text] [Related]
40. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]